QR-Code

Proteomic Associations of Adverse Outcomes in Human Heart Failure

Background Identifying novel molecular drivers of disease progression in heart failure (HF) is a high‐priority goal that may provide new therapeutic targets to improve patient outcomes. The authors investigated the relationship between plasma proteins and adverse outcomes in HF and their putative ca...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Marie‐Joe Dib, Michael G. Levin, Lei Zhao, Ahmed Diab, Zhaoqing Wang, Christina Ebert, Oday Salman, Joe David Azzo, Sushrima Gan, Payman Zamani, Jordana B. Cohen, Dipender Gill, Stephen Burgess, Loukas Zagkos, Vanessa van Empel, A. Mark Richards, Rob Doughty, Ernst R. Rietzschel, Karl Kammerhoff, Erika Kvikstad, Joseph Maranville, Peter Schafer, Dietmar A. Seiffert, Francisco Ramirez‐Valle, David A. Gordon, Ching‐Pin Chang, Ali Javaheri, Douglas L. Mann, Thomas P. Cappola, Julio A. Chirinos
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley 2024-03-01
Schriftenreihe:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Schlagworte:
heart failure
HFrEF
Mendelian randomization
proteomics
Online-Zugang:https://www.ahajournals.org/doi/10.1161/JAHA.123.031154
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge